At a glance
One directly relevant hair-follicle study is included, alongside an identity cross-check explaining why a superficially similar Tripeptide-3 paper is not AHK-Cu evidence.
Identity & scope
The cited paper examines the copper complex of alanyl-histidyl-lysine. AHK-Cu and GHK-Cu are distinct sequences; their findings should not be substituted.
What the research shows
- Follicle elongation and dermal-papilla-cell proliferation increased under the experimental conditions; the measured reduction in apoptotic cells was not statistically significant.
Critical interpretation
Human tissue does not make this a treatment trial
The follicle experiment supports a local biological hypothesis. It cannot show that a product crosses a scalp or nasal barrier, reaches a comparable exposure or changes a person's hair growth over time. A follow-up clinical study would need a characterised formulation, an appropriate vehicle comparison and objective hair outcomes, rather than counting a cultured follicle as a treated participant. [1]
A naming collision can create false clinical evidence
Tripeptide-3 is not a sufficient identity match. The 2024 emulsion paper specifies dipeptide diaminobutyroyl benzylamide diacetate in its materials section. That chemical identity differs from the copper-bound alanyl-histidyl-lysine in the follicle study. The paper is retained here as a cross-check, not as evidence that AHK-Cu controls facial oil or has been clinically validated. This distinction demonstrates why sequence, chemical identifiers and metal binding matter more than a shared marketing shorthand when selecting references. [1] [2]
Keep excluded material visible
Recording the identity mismatch is useful even though the paper is not support for AHK-Cu. It lets another reader reproduce the exclusion and prevents an appealing clinical result from entering a bibliography through a name match alone. More references would not improve this review if they tested another chemical. [2]
Limitations & uncertainties
- Isolated follicles do not reproduce long-term scalp exposure, formulation delivery or clinical hair counts.
Open research questions
- Would a characterised formulation produce a durable, independently replicated benefit in a controlled human trial?
Selected papers & source records
Download bibliography1. The effect of tripeptide-copper complex on human hair growth in vitro (opens in a new tab)
Pyo HK, Yoo HG, Won CH, et al. (2007). Archives of Pharmacal Research. DOI: 10.1007/BF02978833 (opens in a new tab) · PMID 17703734
- Design & population
- Isolated human follicles and cultured dermal papilla cells.
- What the study found
- Elongation and proliferation signals increased; apoptosis findings were mixed.
- Limits on interpretation
- No clinical hair-restoration endpoint.
2. Microemulsions and Nanoemulsions for Topical Delivery of Tripeptide-3: From Design of Experiment to Anti-Sebum Efficacy on Facial Skin (opens in a new tab)
Magrode N, Poomanee W, Kiattisin K, Ampasavate C (2024). Pharmaceutics. DOI: 10.3390/pharmaceutics16040554 (opens in a new tab) · PMID 38675215
- Design & population
- Identity cross-check of a formulation paper that uses the name Tripeptide-3; this is not an AHK-Cu study.
- What the study found
- Materials identify dipeptide diaminobutyroyl benzylamide diacetate, CAS823202-99-9, rather than alanyl-histidyl-lysine copper.
- Limits on interpretation
- Included to prevent misattribution. Its formulation and sebum results are not AHK-Cu efficacy evidence.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
Search & review scope
Targeted primary-record search.. Checked 9 November 2026.
One direct AHK-Cu follicle study plus a full-text materials identity cross-check of the 2024 Tripeptide-3 paper.
Not an exhaustive review or proof that no additional AHK-Cu research exists. The identity-only reference is excluded from AHK-Cu human efficacy evidence.
Recorded search terms
- site.pubmed.ncbi.nlm.nih.gov AHK Cu human clinical hair trial
- The effect of tripeptide-copper complex on human hair growth in vitro retracted
- AHK Cu tripeptide-3 microemulsion nanoemulsion Magrode 2024 PubMed
- Microemulsions and Nanoemulsions Dipeptide 823202
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. AHK-Cu: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/uk/research/library/ahk-cu.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.